Xinjie Lu received his B.S. degree in biology from the Biology Department, Henan Normal University, Henan, China, in 1974. He served as an Assistant Professor at the same university, involved in undergraduate student training and teaching of biochemistry, organic chemistry, inorganic and analysis chemistry, experiments in biochemistry, and experiments in inorganic and organic chemistry. In 1985, he served as an Associate Professor involved in graduate teaching. In 1995, he received his Ph.D. degree in biochemistry from the Imperial College in London, UK. His Ph.D. work was based on structural and functional studies on dendroaspin, a disintegrin-like protein originally isolated from the venom of the snake Dendroaspisjamesoni. In the following years, he has been a Senior Postdoctoral Research Fellow at the Thrombosis Research Institute (TRI), London, a Lecturer and the Head of the Protein Biochemistry Section in TRI, in 1997, a Senior Lecturer and the Head of Molecular Immunology Section in TRI in 2002, and a Professor of molecular immunology at TRI in 2012. His research focuses on atherosclerosis study including inflammation and tissue repair in atherosclerosis. The aim of this research is to develop a protein-based as well as DNA-based vaccine against atherosclerosis. He is the Principal Investigator on the Vaccine project in TRI-London and a Coordinator of international collaborators including the University of Szeged, Szeged, Hungary and TRI-Bangalore, India. He is in charge of the experimental design, data collection, and interpretation. He is involved in supervising Ph.D. students and postdoctoral research fellows who were funded by the British Heart Foundation (four grants) and Weston Foundations (two grants). He has been a Member of the Biochemical Society since 1992 and an Invited Reviewer for BBSRC grant application and several journals. He was invited as a Managing Editor of the Frontiers in Bioscience Journal in 2008.
Biography Updated on 11 April 2012